UBS Upgrades Nuveen Churchill Direct to Buy, Lowers Price Target to $13
Benzinga Newsdesk 2 months ago
NewsUpgradesAnalyst RatingsPrice Target
UBS analyst Melissa Wedel upgrades Nuveen Churchill Direct (NYSE:NCDL) from Neutral to Buy and lowers the price target from $14.75 to $13.
UBS analyst Melissa Wedel upgrades Nuveen Churchill Direct (NYSE:NCDL) from Neutral to Buy and lowers the price target from $14.75 to $13.